Alnylam Pharmaceuticals: Peers

The FY2025 (Dec) proxy of Alnylam Pharmaceuticals names 12 peer companies for pay. Among Alnylam Pharmaceuticals and these peers, CEO pay was 4th highest of 5 and total shareholder return was the highest of 5.

4th highest of 5in Alnylam Pharmaceuticals and its pay peers, FY2025 (Dec) by CEO pay:

$7.3M$32.1M

1st highest of 5in Alnylam Pharmaceuticals and its pay peers, FY2025 (Dec) by total shareholder return:

$28$306

Pay peer group, FY2025 (Dec) proxy

Incyte
Gilead Sciences
Moderna
Regeneron Pharmaceuticals
BeOne Medicines, Ltd.Not disclosedNot disclosed
BioMarin Pharmaceutical Inc.Not disclosedNot disclosed
BiogenNot disclosedNot disclosed
Exact Sciences CorporationNot disclosedNot disclosed
Neurocrine Biosciences, Inc.Not disclosedNot disclosed
Sarepta Therapeutics, Inc.Not disclosedNot disclosed
United Therapeutics CorporationNot disclosedNot disclosed
Vertex Pharmaceuticals IncorporatedNot disclosedNot disclosed
12 companies

Changes by year

FY2025 (Dec) proxy

  • AddedGilead Sciencespay peer groupbecause both companies directly compete with us for talent
  • AddedRegeneron Pharmaceuticalspay peer groupbecause both companies directly compete with us for talent
  • RemovedExelixis, Inc.pay peer groupdue to their low market capitalizations relative to our selection criteria
  • RemovedJazz Pharmaceuticals plcpay peer groupdue to their low market capitalizations relative to our selection criteria

FY2023 (Dec) proxy

  • AddedBiogenpay peer groupThe PC&C committee also determined that it would be appropriate to add three companies (Biogen Inc., Moderna Inc. and Vertex Pharmaceuticals Incorporated) to our peer group based primarily on our financial and business position as a maturing commercial company
  • AddedModernapay peer groupThe PC&C committee also determined that it would be appropriate to add three companies (Biogen Inc., Moderna Inc. and Vertex Pharmaceuticals Incorporated) to our peer group based primarily on our financial and business position as a maturing commercial company
  • AddedVertex Pharmaceuticals Incorporatedpay peer groupThe PC&C committee also determined that it would be appropriate to add three companies (Biogen Inc., Moderna Inc. and Vertex Pharmaceuticals Incorporated) to our peer group based primarily on our financial and business position as a maturing commercial company
  • RemovedAcceleron Pharma, Inc.pay peer groupdue to changes in market capitalization and/or revenue or because they were acquired in a business transaction
  • RemovedAlexion Pharmaceuticals, Inc.pay peer groupdue to changes in market capitalization and/or revenue or because they were acquired in a business transaction
  • RemovedNovavax, Inc.pay peer groupdue to changes in market capitalization and/or revenue or because they were acquired in a business transaction
  • RemovedUltragenyx Pharmaceutical Inc.pay peer groupdue to changes in market capitalization and/or revenue or because they were acquired in a business transaction

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.